Keyphrases
Long QT Syndrome
100%
Molecular Pharmacology
100%
Flecainide
100%
Sodium Channel mutation
100%
Na+ Channel
80%
Lidocaine
60%
EC50
60%
Na +
20%
High Sensitivity
20%
C-terminus
20%
Clinically Significant
20%
C-terminal Region
20%
HEK293 Cells
20%
Disease Phenotype
20%
SCN5A
20%
Congenital Long QT Syndrome
20%
Steady-state Inactivation
20%
Ventricular Repolarization
20%
Therapeutic Effect
20%
1-form
20%
Gene mutation
20%
Multiple mutations
20%
Pharmacological Response
20%
Repetitive Stimulation
20%
Tonic Block
20%
Use-dependent Block
20%
Channel Interaction
20%
Biochemistry, Genetics and Molecular Biology
Sodium Channel
100%
Long QT Syndrome
100%
Flecainide
83%
Wild Type
66%
Lidocaine
50%
EC50
50%
C-Terminus
33%
Steady State
16%
HEK 293 Cells
16%
Repolarization
16%
Gene Mutation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Long QT Syndrome
100%
Sodium Channel
100%
Molecular Pharmacology
100%
Flecainide
83%
Lidocaine
50%
EC50
50%
Disease
16%
Therapeutic Effect
16%
Neuroscience
Sodium Channel
100%
Molecular Pharmacology
100%
Long QT Syndrome
100%
Flecainide
83%
Lidocaine
50%
C-Terminus
33%
HEK 293 Cells
16%
Gene Mutation
16%